2017
DOI: 10.1089/ten.tea.2015.0498
|View full text |Cite
|
Sign up to set email alerts
|

Tendon-Derived Extracellular Matrix Enhances Transforming Growth Factor-β3-Induced Tenogenic Differentiation of Human Adipose-Derived Stem Cells

Abstract: Because of the limited and unsatisfactory outcomes of clinical tendon repair, tissue engineering approaches using adult mesenchymal stem cells are being considered a promising alternative strategy to heal tendon injuries. Successful and functional tendon tissue engineering depends on harnessing the biochemical cues presented by the native tendon extracellular matrix (ECM) and the embedded tissue-specific biofactors. In this study, we have prepared and characterized the biological activities of a soluble extrac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
52
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 60 publications
(55 citation statements)
references
References 62 publications
3
52
0
Order By: Relevance
“…Growth factors used for induction of tenogenic differentiation mainly include transforming growth factor-β family members (TGF-β [47,51,53,60,66,86,88] [49]. A promising stepwise differentiation approach has also been reported using TGF-β1 followed by connective tissue growth factor (CTGF) [54].…”
Section: In Vitro Evidencementioning
confidence: 99%
“…Growth factors used for induction of tenogenic differentiation mainly include transforming growth factor-β family members (TGF-β [47,51,53,60,66,86,88] [49]. A promising stepwise differentiation approach has also been reported using TGF-β1 followed by connective tissue growth factor (CTGF) [54].…”
Section: In Vitro Evidencementioning
confidence: 99%
“…One strategy for stem cell‐based rotator cuff repair harnesses their multipotent capacity to direct differentiation toward a tendon or fibrocartilage phenotype. Differentiation can be carried out in vitro to create an engineered tendon/enthesis construct prior to implantation, or naive MSCs can be delivered within a biomimetic matrix to promote the proper cell fate in situ . Commonly used scaffolds for rotator cuff include electrospun fibers, xenograft tendon scaffolds, or hydrogels (typically fibrin or type I collagen gels) .…”
Section: Stem Cell‐based Therapies For Rotator Cuff Repairmentioning
confidence: 99%
“…Differentiation can be carried out in vitro to create an engineered tendon/enthesis construct prior to implantation, or naive MSCs can be delivered within a biomimetic matrix to promote the proper cell fate in situ. [116][117][118][119] Commonly used scaffolds for rotator cuff include electrospun fibers, xenograft tendon scaffolds, or hydrogels (typically fibrin or type I collagen gels). 43,59,[120][121][122][123] The use of a carrier vehicle is advantageous since it ensures proper localization of delivered cells; the environment provided by the scaffolds has the additional potential to improve host cell proliferation or differentiation.…”
Section: Directed Differentiation Of Stem Cells In Vivomentioning
confidence: 99%
“…8,9 In addition, the ECMs promote differentiation of precursor cells. 10,11 Scaffolds for ligament tissue engineering can be produced by various techniques such as braiding, embroidering, 3D printing, electrospinning, electro hydrodynamic jet printing and combinations of them. 6,10,[12][13][14][15] Aligned, interwoven and multilayered composite structures most likely reflect the natural aligned ligament ultrastructure and biomechanics.…”
mentioning
confidence: 99%
“…The presence of stimulatory GFs or natural ligament ECM is especially advantageous if precursor cells are used to produce a tissue engineered neotendon or-ligament. 11 Multipotent stromal cells (MSCs) are highly attractive for musculoskeletal tissue reconstruction due to their favorable properties such as high proliferative capacity, plasticity, differentiation potential, low immunogenicity, immunomodulatory capacity, trophic effects and higher availability. 22 Harvesting MSCs presents lower donor site morbidity than harvesting primary tissue-specific resident cells such as ligamentocytes.…”
mentioning
confidence: 99%